An FAQ on the potential impact of COVID-19 on thrombotic and/or bleeding risk from ACC\u27s Science and Quality Committee summarize the current data on the risk, potential need for hemostasis/coagulation testing, VTE prophylaxis, and therapeutic anticoagulation in patients with COVID-19 without confirmed/suspected thrombosis
